v3.26.1
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME/(LOSS) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
REVENUE        
Collaboration revenue $ 326.1 $ 219.7 $ 624.5 $ 405.3
License and other revenue - total [1] 61.4 35.4 68.1 44.8
Total revenue 387.5 255.1 692.6 450.1
Cost of collaboration revenue (136.0) (94.9) (311.4) (164.4)
Cost of license and other revenue (1.4) (3.1) (1.9) (4.9)
Research and development expenses (96.0) (98.3) (181.7) (200.2)
Administrative expenses (33.0) (32.6) (73.0) (64.1)
Selling and distribution expenses (63.4) (48.1) (113.5) (89.1)
Other operating expenses [2] 0.0 0.0 (3.2) (1.0)
Operating income (loss) 57.7 (21.9) 7.9 (73.6)
Finance costs (5.8) (5.2) (11.3) (10.3)
Finance income 5.6 10.4 12.9 22.5
Other expense, net (2.0) (108.1) (7.1) (162.6)
Income (loss) before tax 55.5 (124.8) 2.4 (224.0)
Income tax expense 22.3 0.6 23.5 2.4
Net income (loss) $ 33.2 $ (125.4) $ (21.1) $ (226.4)
EARNINGS (LOSS) PER SHARE        
Basic (in dollars per share) $ 0.09 $ (0.34) $ (0.06) $ (0.62)
Diluted (in dollars per share) $ 0.09 $ (0.34) $ (0.06) $ (0.62)
OTHER COMPREHENSIVE INCOME (LOSS)        
Exchange differences on translation of foreign operations $ (1.3) $ 124.2 $ (0.8) $ 184.9
Other comprehensive income (loss), net of tax (1.3) 124.2 (0.8) 184.9
TOTAL COMPREHENSIVE INCOME (LOSS) $ 31.9 $ (1.2) $ (21.9) $ (41.5)
[1]
*Certain prior year amounts included within other revenue have been combined into the license and other revenue line for comparative purposes.
[2]
** Certain prior year amounts have been reclassified to present loss on asset impairment into the other operating expenses line for comparative purposes.